Starting Dose of Paroxetine (Paxil)
The recommended starting dose of paroxetine (Paxil) is 20 mg once daily, typically administered in the morning with or without food. 1
Dosing Guidelines by Indication
Major Depressive Disorder
- Initial dose: 20 mg once daily
- Dose adjustments: May increase by 10 mg/day increments at intervals of at least 1 week
- Maximum dose: 50 mg/day
- Effective dose range in clinical trials: 20-50 mg/day
Anxiety Disorders
Panic Disorder:
- Initial dose: 10 mg once daily
- Target dose: 40 mg/day
- Maximum dose: 60 mg/day
Obsessive-Compulsive Disorder (OCD):
- Initial dose: 20 mg once daily
- Target dose: 40 mg/day
- Maximum dose: 60 mg/day
Social Anxiety Disorder:
- Initial dose: 20 mg once daily
- Effective dose range: 20-60 mg/day, though evidence suggests no additional benefit above 20 mg/day 1
Generalized Anxiety Disorder:
- Initial dose: 20 mg once daily
- Maximum dose: 50 mg/day, though evidence suggests no additional benefit above 20 mg/day 1
Post-Traumatic Stress Disorder:
- Initial dose: 20 mg once daily
- Dose range: 20-50 mg/day 1
Special Populations
Elderly Patients
- Starting dose should be lower (approximately 50% of the adult starting dose) 2
- Therapeutic dose range: 20-40 mg/day 3
- Paroxetine is generally well tolerated in elderly individuals 4
Patients with Hepatic or Renal Impairment
- Consider dose adjustments for patients with hepatic impairment 2
- Consider dose adjustments for patients with renal impairment 2
Administration Guidelines
- Administer as a single daily dose, usually in the morning
- Can be taken with or without food
- Dose changes should occur at intervals of at least 1 week
- For most patients, 20 mg/day will be the optimal dose 3
- If inadequate response after 1-3 weeks, increase dose in 10-mg increments at weekly intervals 3
Important Clinical Considerations
- Paroxetine has the highest potency for serotonin reuptake inhibition among SSRIs 5
- Unlike some other SSRIs, paroxetine has weak affinity for muscarinic cholinergic receptors, which may contribute to certain side effects 5
- Steady-state levels are achieved after 4-14 days of treatment 5
- The elimination half-life of approximately 21 hours is consistent with once-daily dosing 5
Common Pitfalls to Avoid
- Avoid abrupt discontinuation to prevent withdrawal syndrome
- Avoid concurrent use with MAOIs due to risk of serotonin syndrome
- Be aware of potential drug interactions as paroxetine is both a substrate and inhibitor of cytochrome P450 2D6 enzyme 5
- Monitor for common side effects including nausea, sexual dysfunction, somnolence, headache, and dry mouth 4
Paroxetine is generally well tolerated with a safety profile similar to other SSRIs, making it an appropriate first-line treatment option for major depressive disorder and various anxiety disorders 4.